Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

Bass, Berry & Sims Recommended Firm for M&A – Middle-Market (sub-$500M) by The Legal 500 United States 2016

June 24, 2016

Bass, Berry & Sims was recommended as a United States firm for "M&A – Middle-Market (sub-$500M)" by The Legal 500 United States 2016 guide. The 10th annual edition of The Legal 500 United States compiled research from law firms, peers and clients nationwide to recommend the top law firms in various categories. According to the guide:

Bass, Berry & Sims PLC has particularly strong government contractor and healthcare M&A practices. The team assisted Engility Holdings with its acquisition of TASC, advised Gen Cap America on its acquisition of Aero Systems Engineering, and acted for Emergent BioSolutions in the government contract aspects of its acquisition of assets relating to a contract with the Defense Threat Reduction Agency. In the healthcare space, it advised Little Hills Healthcare on its sale to CenterPointe Behavioral Health System, and acted for Healthways in its disposition of Navvis Healthcare. Todd Overman in Washington DC is chair of the firm's government contracts practice and has more than a decade of experience advising companies on doing business with the federal government. Nashville-based Riney Green has 25 years-plus experience in guiding middle-market companies and private equity sponsors through M&A, dispositions and other strategic growth initiatives, and provides M&A and corporate governance counsel to a publicly traded long-term care company. Allen Overby, also in Nashville, focuses mainly on public company M&A transactions in the $50m-$1bn range, with an emphasis on cross-border M&A and strategic transactions.

To read more about the recognition, please visit The Legal 500 United States website.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.